Request Appointment
160 East 53rd StreetNew York, NY 10022
Overview of Dr. Santomasso
Dr. Bianca Santomasso is a neurologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Weill Cornell Medicine and has been in practice 9 years. She is one of 66 doctors at Memorial Sloan Kettering Cancer Center who specialize in Neurology. She has more than 50 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2009 - 2013
Weill Cornell MedicineClass of 2008
Certifications & Licensure
NJ State Medical License 2020 - 2027
NY State Medical License 2013 - 2026
American Board of Psychiatry and Neurology Neurology- UCNSNeuro-Oncology
Publications & Presentations
PubMed
- Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis.Dorte Lisbet Nielsen, Carsten Bogh Juhl, Inna Markovna Chen, Yinghong Wang, Ole Haagen Nielsen
Cancer Treatment Reviews. 2025-11-01 - Phase 2 study of amivantamab plus lazertinib in previously-treated patients with EGFR mutant lung cancers with brain and leptomeningeal metastases.Monica F Chen, Jake June-Koo Lee, Noura J Choudhury, Angela B Hui, Mark Y Jeng
Journal of Thoracic Oncology. 2025-10-23 - Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors.Subhiksha Nandakumar, Miika Mehine, Yelena Kemel, Chaitanya Bandlamudi, Diana Mandelker
Acta Neuropathologica. 2025-09-12
Abstracts/Posters
- Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T CellsBianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell LymphomaBianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)Bianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Neurotoxicity From CAR T-Cell Therapy: Why It Happens, How to Manage It, and Who Is at Risk?ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Incysus Announces Formation of Scientific Advisory BoardAugust 24th, 2017
Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory BoardJanuary 12th, 2017
Grant Support
- Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell TherapySLOAN-KETTERING INST CAN RESEARCH2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










